Pages that link to "Q45942484"
Jump to navigation
Jump to search
The following pages link to Comparative safety and efficacy of clarithromycin and amoxicillin/clavulanate in the treatment of acute otitis media in children. (Q45942484):
Displaying 14 items.
- Reported rates of diarrhea following oral penicillin therapy in pediatric clinical trials (Q28083234) (← links)
- The new antibiotics (Q34114448) (← links)
- Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media (Q35048037) (← links)
- Macrolides: A Canadian Infectious Disease Society position paper (Q36170393) (← links)
- Choosing the right macrolide antibiotic. A guide to selection (Q37883369) (← links)
- Macrolide antibiotics in paediatric infectious diseases (Q37885246) (← links)
- Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients (Q38547530) (← links)
- The antibiotic treatment of acute otitis media and sinusitis in children (Q41451323) (← links)
- Clarithromycin for children (Q42591036) (← links)
- Indicators show differences in antibiotic use between general practitioners and paediatricians (Q60672992) (← links)
- In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections (Q64115187) (← links)
- Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children (Q72038201) (← links)
- Efficacy of twice-daily dosing of amoxycillin/clavulanate in acute otitis media in children (Q73410505) (← links)
- Safety and tolerability of clarithromycin administered to children at higher-than-recommended doses (Q79538058) (← links)